1 |
Falck-Ytter Y, Younossi ZM, Marchesini G, MaCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001;21:17-26
DOI
ScienceOn
|
2 |
Chitturi S, Weltman M, Farrell GC, McDonald D, Liddle C, samarasinghe D, et al. HFE mutations, hepatic iron, and fibrosis : ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology 2002;36:142-9
DOI
ScienceOn
|
3 |
Caturelli E, Squillatne MM, Andriulli A, Rapaccini GL. Hypoechoic lesions in the 'bright liver' : A reliable indicator of fatty change. A prospective study. J Gastroenterol Hepatol 1992;7:469-72
DOI
ScienceOn
|
4 |
Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:955-6
DOI
ScienceOn
|
5 |
Kim SK, Kim SH, Rhee YM, Choi SH, Cho YL, Ahn CW, et al. The comparison of intra-abdominal fat distance and visceral adipose tissue area or visceral fat to skeletal muscle area ratio measured by computed tomography. Korean Journal of Medicine 2003;64:49-59
|
6 |
Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease : pathogenesis and the role of antioxidants. Nutr Rev 2002;60:289-93
DOI
ScienceOn
|
7 |
Kim WR, Poterucha JJ, Porayko MK, Dickson ER, Steers JL, Wiesner RH. Recurrence of nonalcoholic steatohepatitis following liver transplantation. Transplantation 1996;62:1802
DOI
PUBMED
|
8 |
Clark JM, Brancati FL, Diehl AE. Nonalcoholic fatty liver disease : the most common cause of abnormal liver enzymes in the U.S. population[abstract]. Gastroenterology 2001;120:A-65.
|
9 |
Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease : A spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9
|
10 |
Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease : predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121: 91-100
DOI
ScienceOn
|
11 |
Wanless IR, Lentz JS. Fatty liver hepatitis(steatohepatitis) and obesity : an autopsy study with analysis of risk factors. Hepatology 1990;12:1106-10
DOI
PUBMED
|
12 |
Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis : Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8
|
13 |
Harrison SA, Kadakia S, Lang KA, Schenker S. Nonalcoholic steatohepatitis : What we know in the new millennium. Am J Gastroenterol 2001;97:2714-24
|
14 |
Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003;143:500-5
DOI
ScienceOn
|
15 |
Agrawal S, Bonkovsky H. Management of nonalcoholic steatohepatitis : an analytic review. J Clin Gastroenterol 2002;35:253-61
DOI
ScienceOn
|
16 |
Yu AS, Keeffe EB. Nonalcohoic fatty liver disease. Rev Gastroenterol Disord 2002;2:11-9
|
17 |
Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-62
DOI
PUBMED
|
18 |
Tornaghi G, Raiteri R, Pozzato C, Rispoli A, Bramani M, Cipolat M, et al. Anthropometric or ultrasonic measurements in assessment of visceral fat? : a comparative study. Int J Obes Relat Metab Disord 1994;18:771-5
|
19 |
Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitiative insulin sensitivity check index : a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10
DOI
ScienceOn
|
20 |
Contos MJ, Sanyal AJ. The clinicopathologic spectrum and management of nonalcoholic fatty liver disease. Adv Anat Pathol 2002;9:37-51
DOI
ScienceOn
|
21 |
Diehl AM. Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol 2002;282:G1-5
|
22 |
Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, et al. Ursodeoxycholic acid or clofibrate in the treatment of nonalcoholic induced steatohepatitis : a pilot study. Hepatology 1996;23:74-80
|
23 |
Kaplan LM. Leptin, obesity, and liver disease. Gastroenterology 1998;115:997-1001
DOI
PUBMED
ScienceOn
|
24 |
George DK, Goldwurm S, Macdonald GA, Cowley LL, Walker NI, Ward PJ, et al. Increased hepatid iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998;114:311-8
DOI
ScienceOn
|
25 |
Sakugawa H, Nakayoshi T, Kobashigawa K, Nakasone H, Kawakami Y, Yamashiro T, et al. Alanine aminotransferase elevation not associated with fatty liver is frequently seen in obese japanese women. Eur J Clin Nutr 2004;58:1-5
DOI
ScienceOn
|
26 |
Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver disease : prospective cohort study. BMJ 2004;328:983
DOI
ScienceOn
|
27 |
Hoyumpa AM Jr, Greene HL, Dunn GD, Schencker S. Fatty liver : biochemical and clinical considerations. Am J Dig Dis 1975;20:1142-70
DOI
ScienceOn
|
28 |
Cortez-Pinto H, Camilo ME, Baptista A, De Oliveria AG, De Moura MC. Non-alcoholic fatty liver : another feature of the metabolic syndrome? Clin Nutr 1999;18:353-8
DOI
ScienceOn
|
29 |
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment : insulin resistance and B-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-9
DOI
ScienceOn
|
30 |
Hrebicek J, Janout V, Malincikova J, Horakovaj D, Cizek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002;87:144-7
DOI
ScienceOn
|
31 |
Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991;43:26-31
DOI
ScienceOn
|
32 |
Sung YK, choi WH, Lee CB, Park YS. Insulin resistance measured by QUICKI and obesity in type 2 diabetic patients. Journal of Korean Society for the Study of Obesity 2003;12:162-72
|
33 |
Foster KJ, Dewbury KC, Griffith AH. The accuracy of ultrasound in detection of fatty infiltration of the liver. Br J Radiology 1980;53:440-2
DOI
ScienceOn
|
34 |
Day C, James O. Steatohepatitis : A tale of two 'hits'? Gastroenterology 1998;114:842-5
DOI
ScienceOn
|
35 |
Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver fibrosis in overweight patients. Gastroenterology 2000;118:1117-23
DOI
ScienceOn
|
36 |
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31
DOI
ScienceOn
|
37 |
McCullough AJ. Update on nonalcoholic fatty liver disease. J clin Gastroenterol 2002;34:255-62
DOI
PUBMED
ScienceOn
|
38 |
Park HS, Shin ES, Kim MW, Kim KM. Improvement of liver function by weight control in children with fatty liver. Korean J Nutrition 1995;28:629-35
|
39 |
Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K. in situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver disease. J Hepatol 2002;37:56-62
DOI
ScienceOn
|
40 |
Baffy G, Zhang CY, Glickman JN, Lowell BB. Obesityrelated fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. Hepatology 2002;35:753-61
DOI
ScienceOn
|
41 |
Sanyal AJ. Nonalcoholic steatohepatitis. Clin Perspect Gastroenterol 2000;3:129-39
|